A major advance for treating hepatitis C is likely headed to market after government advisors backed two new drugs: telaprevir and boceprivir.
Continue reading here:
FDA Panel Backs 2 Hepatitis C Drugs
You must be logged in to post a comment.
Posted by
on April 28, 2011. Filed under